Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy: A new strategy for host-directed therapy of tuberculosis
Seungwha Paik, Jin Kyung Kim, Chaeuk Chung, et al.
Virulence (2018) Vol. 10, Iss. 1, pp. 448-459
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

New insights into the evasion of host innate immunity by Mycobacterium tuberculosis
Qiyao Chai, Lin Wang, Cui Hua Liu, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 9, pp. 901-913
Open Access | Times Cited: 216
Therapeutic host-directed strategies to improve outcome in tuberculosis
Carly Young, Gerhard Walzl, Nelita du Plessis
Mucosal Immunology (2019) Vol. 13, Iss. 2, pp. 190-204
Open Access | Times Cited: 163
Autophagy restricts Mycobacterium tuberculosis during acute infection in mice
Guillaume Golovkine, Allison W. Roberts, Huntly M. Morrison, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 819-832
Open Access | Times Cited: 51
Vitamin D-Cathelicidin Axis: at the Crossroads between Protective Immunity and Pathological Inflammation during Infection
Chaeuk Chung, Prashanta Silwal, In-Soo Kim, et al.
Immune Network (2020) Vol. 20, Iss. 2
Open Access | Times Cited: 112
Host‐directed therapy to combat mycobacterial infections*
Gül Kilinç, Anno Saris, Tom H. M. Ottenhoff, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 62-83
Open Access | Times Cited: 100
Mitophagy and Innate Immunity in Infection.
Dong‐Hyung Cho, Jin Kyung Kim, Eun‐Kyeong Jo
PubMed (2020) Vol. 43, Iss. 1, pp. 10-22
Closed Access | Times Cited: 73
The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy
Retsepile E. Maphasa, Mervin Meyer, Admire Dube
Frontiers in Cellular and Infection Microbiology (2021) Vol. 10
Open Access | Times Cited: 65
M. tuberculosis PknG manipulates host autophagy flux to promote pathogen intracellular survival
Pupu Ge, Zehui Lei, Yang Yu, et al.
Autophagy (2021) Vol. 18, Iss. 3, pp. 576-594
Open Access | Times Cited: 62
A guide to membrane atg8ylation and autophagy with reflections on immunity
Vojo Deretić, Michael Lazarou
The Journal of Cell Biology (2022) Vol. 221, Iss. 7
Open Access | Times Cited: 57
Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy
Eveline Torfs, Tatiana Piller, Paul Cos, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2868-2868
Open Access | Times Cited: 60
Interplay between host and pathogen: immune defense and beyond
Eun‐Kyeong Jo
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 12, pp. 1-3
Open Access | Times Cited: 60
Autophagy-activating strategies to promote innate defense against mycobacteria
Yi Sak Kim, Prashanta Silwal, Soo Yeon Kim, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 12, pp. 1-10
Open Access | Times Cited: 58
Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL ofMycobacterium Tuberculosis
Niranjan Kumar, Rakesh Srivastava, Amresh Prakash, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 11, pp. 3396-3410
Closed Access | Times Cited: 55
Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
Valdenizia R. Silva, Sara P. Neves, Luciano de S. Santos, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3461-3461
Open Access | Times Cited: 53
Advances and Potentials of Polydopamine Nanosystem in Photothermal-Based Antibacterial Infection Therapies
Shuhao Fan, Wensen Lin, Yifan Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Chemical modulation of SQSTM1/p62-mediated xenophagy that targets a broad range of pathogenic bacteria
Yoon Jee Lee, Jin Kyung Kim, Chan Hoon Jung, et al.
Autophagy (2022) Vol. 18, Iss. 12, pp. 2926-2945
Open Access | Times Cited: 34
NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 17
Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon
Amol D. Gholap, Pankaj R. Khuspe, Sagar R. Pardeshi, et al.
Advanced Therapeutics (2024)
Open Access | Times Cited: 8
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
Stephen Cerni, Dylan Shafer, Kimberly To, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 2, pp. 232-232
Open Access | Times Cited: 49
The Lipid Virulence Factors of Mycobacterium tuberculosis Exert Multilayered Control over Autophagy-Related Pathways in Infected Human Macrophages
Aïcha Bah, Merlin Sanicas, Jérôme Nigou, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 666-666
Open Access | Times Cited: 42
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
Matteo Puccetti, Styliani Xiroudaki, Maurizio Ricci, et al.
Pharmaceutics (2020) Vol. 12, Iss. 7, pp. 624-624
Open Access | Times Cited: 42
Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
Filia Stephanie, Mutiara Saragih, Usman Sumo Friend Tambunan
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 592-592
Open Access | Times Cited: 39
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance
Summaya Perveen, Diksha Kumari, Kuljit Singh, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114066-114066
Closed Access | Times Cited: 39
Nano drug delivery in intracellular bacterial infection treatments
Seyed Mostafa Hosseini, Mohammad Taheri‬, Fatemeh Nouri, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112609-112609
Open Access | Times Cited: 37
Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis
Pavithra Sampath, Krisna Moorthi Periyasamy, Uma Devi Ranganathan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top